Shivalik Rasayan on Monday announced that the company has successfully submitted its first CEP for Europe in eCTD format for BUSULPHAN to EQDM.
Last week, the company had accomplished a major milestone by submitting its first US Drug Master File (DMF) in eCTD format for BORTEZOMIB through ESG gateway to USFDA.
At around 1.47 pm, the company stock was trading at Rs961.70 per piece flat compared to the previous closing on Sensex.
The stock has touched an intraday high and low of Rs1001 per piece and Rs940 per piece respectively.